tetano
Editor, Senior Moderator
Int J Mol Sci
. 2021 Apr 29;22(9):4691.
doi: 10.3390/ijms22094691.
ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis
Anastasia V Poznyak[SUP] 1 [/SUP], Evgeny E Bezsonov[SUP] 2 3 [/SUP], Ali H Eid[SUP] 4 5 [/SUP], Tatyana V Popkova[SUP] 6 [/SUP], Ludmila V Nedosugova[SUP] 7 [/SUP], Antonina V Starodubova[SUP] 8 9 [/SUP], Alexander N Orekhov[SUP] 1 2 3 [/SUP]
Affiliations
Abstract
COVID-19 is a highly contagious new infection caused by the single-stranded RNA Sars-CoV-2 virus. For the first time, this infection was recorded in December 2019 in the Chinese province of Wuhan. The virus presumably crossed the interspecies barrier and passed to humans from a bat. Initially, the disease was considered exclusively in the context of damage to the respiratory system, but it quickly became clear that the disease also entails serious consequences from various systems, including the cardiovascular system. Among these consequences are myocarditis, myocardial damage, subsequent heart failure, myocardial infarction, and Takotsubo syndrome. On the other hand, clinical data indicate that the presence of chronic diseases in a patient aggravates the course and outcome of coronavirus infection. In this context, the relationship between COVID-19 and atherosclerosis, a condition preceding cardiovascular disease and other disorders of the heart and blood vessels, is particularly interesting. The renin-angiotensin system is essential for the pathogenesis of both coronavirus disease and atherosclerosis. In particular, it has been shown that ACE2, an angiotensin-converting enzyme 2, plays a key role in Sars-CoV-2 infection due to its receptor activity. It is noteworthy that this enzyme is important for the normal functioning of the cardiovascular system. Disruptions in its production and functioning can lead to various disorders, including atherosclerosis.
Keywords: ACE2; COVID-19; atherosclerosis; coronavirus disease.
. 2021 Apr 29;22(9):4691.
doi: 10.3390/ijms22094691.
ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis
Anastasia V Poznyak[SUP] 1 [/SUP], Evgeny E Bezsonov[SUP] 2 3 [/SUP], Ali H Eid[SUP] 4 5 [/SUP], Tatyana V Popkova[SUP] 6 [/SUP], Ludmila V Nedosugova[SUP] 7 [/SUP], Antonina V Starodubova[SUP] 8 9 [/SUP], Alexander N Orekhov[SUP] 1 2 3 [/SUP]
Affiliations
- PMID: 33946649
- DOI: 10.3390/ijms22094691
Abstract
COVID-19 is a highly contagious new infection caused by the single-stranded RNA Sars-CoV-2 virus. For the first time, this infection was recorded in December 2019 in the Chinese province of Wuhan. The virus presumably crossed the interspecies barrier and passed to humans from a bat. Initially, the disease was considered exclusively in the context of damage to the respiratory system, but it quickly became clear that the disease also entails serious consequences from various systems, including the cardiovascular system. Among these consequences are myocarditis, myocardial damage, subsequent heart failure, myocardial infarction, and Takotsubo syndrome. On the other hand, clinical data indicate that the presence of chronic diseases in a patient aggravates the course and outcome of coronavirus infection. In this context, the relationship between COVID-19 and atherosclerosis, a condition preceding cardiovascular disease and other disorders of the heart and blood vessels, is particularly interesting. The renin-angiotensin system is essential for the pathogenesis of both coronavirus disease and atherosclerosis. In particular, it has been shown that ACE2, an angiotensin-converting enzyme 2, plays a key role in Sars-CoV-2 infection due to its receptor activity. It is noteworthy that this enzyme is important for the normal functioning of the cardiovascular system. Disruptions in its production and functioning can lead to various disorders, including atherosclerosis.
Keywords: ACE2; COVID-19; atherosclerosis; coronavirus disease.